Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
Abstract Cannabidiol (CBD) is the main pharmacologically active phytocannabinoid. CBD exerts an analgesic effect in several pain models, does not have side effects and has low toxicity. The data about CBD mechanisms of action in pain and its therapeutic potential in this area are limited. Here, we t...
Main Authors: | Rosaria Greco, Miriam Francavilla, Chiara Demartini, Anna Maria Zanaboni, Mikael H. Sodergren, Sara Facchetti, Barbara Pacchetti, Michela Palmisani, Valentina Franco, Cristina Tassorelli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-023-01589-y |
Similar Items
-
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
by: Rosaria Greco, et al.
Published: (2023-06-01) -
Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
by: Rosaria Greco, et al.
Published: (2021-09-01) -
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model
by: Chiara Demartini, et al.
Published: (2017-09-01) -
Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
by: Rosaria Greco, et al.
Published: (2023-06-01) -
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
by: Rosaria Greco, et al.
Published: (2022-07-01)